News room
New patent granted to TechnoPhage
Title: Engineered Rabbit Antibody Variable Domains and Uses Thereof Office: Australia Patents Office Date: 16/10/2007 Patent no: 2008246442
TechnoPhage receives FDA clearance to begin human clinical trials of an innovative biological therapeutic
TECHNOPHAGE, a biotechnology company headquartered in Lisbon, Portugal, announced today that the company has received authorization from U.S. Food...
New patent granted to TechnoPhage
New patent granted to TechnoPhage: Title: Antibacterial Phage, Phage Peptides and Methods Of Use Thereof Office: The Registry of Patents Singapore...
TechnoPhage and SIMM sign a Collaboration Agreement
TECHNOPHAGE and SIMM, SHANGHAI INSTITUTE OF MATERIA MEDICA, a state-owned Institute administered and existing under the laws of the People’s...
TECHNOPHAGE and UNIVERSITY OF MACAU sign a Collaboration Agreement
TECHNOPHAGE and UNIVERSITY OF MACAU, a University administered and existing under the laws of Macau Special Administrative Region, China, have...